Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-035581·Coherus Oncology, Inc.
Schedule 13G ownership disclosure
Coherus Oncology Inc
Common Stock, $0.0001 par value per share · CUSIP: 19249H103
Event date: 2025-04-14
- Filing-level shares
- 6,009,514.00
- Percent of class
- 5.2%
- Thomas A. Satterfield, Jr.
Shares: 6,009,514.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-035581
- Form type
- SCHEDULE 13G
- Filer
- Coherus Oncology, Inc.
- CIK
- CIK 1512762
- Filed
- Apr 16, 2025
- Reporting period
- Apr 14, 2025
- Description
- Schedule 13G beneficial ownership